SOPH insider files Rule 144 common stock sale

An affiliate of SOPH has filed a Rule 144 notice to sell 380 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/20/2026.

Rhea-AI Filing Summary

An affiliate of SOPH has filed a Rule 144 notice to sell 380 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/20/2026. The filing lists an aggregate market value of $2,071.00 for this planned sale and shows that the shares were acquired as restricted stock units from the issuer on 01/18/2026.

The notice also details prior sales under a Rule 10b5‑1 trading plan for Manuela Valente over the past three months, including 636 shares sold on 01/06/2026 for $3,015.72, 2,085 shares sold on 01/05/2026 for $9,603.93, 381 shares sold on 12/19/2025 for $1,764.45, and 381 shares sold on 11/19/2025 for $1,530.86.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SOPH shares are planned to be sold under this Rule 144 filing?

The Rule 144 notice states that 380 shares of common stock are planned to be sold, with an aggregate market value of $2,071.00.

When and where are the SOPH shares expected to be sold?

The filing lists an approximate date of sale of 01/20/2026, with the shares to be sold on the NASDAQ market.

Which broker is handling the planned SOPH Rule 144 stock sale?

The planned sale of 380 SOPH common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

How were the SOPH shares to be sold acquired by the seller?

The filing indicates the 380 common shares were acquired on 01/18/2026 as restricted stock units from the issuer, with the same date listed as the payment date and the nature of payment marked as N/A.

What SOPH shares has the seller already sold in the past three months?

Under a Rule 10b5‑1 plan for Manuela Valente, the notice lists several recent sales of SOPH common stock: 636 shares sold on 01/06/2026 for $3,015.72, 2,085 shares sold on 01/05/2026 for $9,603.93, 381 shares sold on 12/19/2025 for $1,764.45, and 381 shares sold on 11/19/2025 for $1,530.86.

What type of securities are covered by this SOPH Rule 144 notice?

The Rule 144 notice covers common stock of the issuer, with 67,847,058 shares outstanding noted in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 04:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002009280
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	MANUELA VALENTE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	380	2071.00	67847058	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/18/2026	Restricted Stock Units	Issuer			380	01/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/06/2026	636	3015.72
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/05/2026	2085	9603.93
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	12/19/2025	381	1764.45
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	11/19/2025	381	1530.86

144: Remarks and Signature

Remarks
Date of Notice	01/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Manuela Valente
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)